简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
FUSEN PHARM
Fusen Pharm (01652.HK): Four Products Proposed to Be Selected in the 12th National Centralized Drug Procurement
Tags：
FUSEN PHARM
01652.HK
proposed to be selected
2026-08-03
FUSEN PHARM(01652.HK): Peramivir Injection Granted Marketing Approval; Domestic Market Size Exceeded RMB800 Million in 2025
Tags：
FUSEN PHARM
01652.HK
New Drug Application
2026-06-26
FUSEN PHARM (01652.HK): Piracetam Injection Approved for Marketing, Market Size Exceeds RMB250 Million in 2025
Tags：
FUSEN PHARM
01652.HK
NMPA Approval
2026-06-16
Featured News
Finance
Xiabuxiabu (00520.HK): First-Half Loss Narrowed Significantly
Finance
JS Global Lifestyle (01691.HK): Expected Net Profit of No Less Than US$12 Million for First Half
Finance
REGENT PACIFIC GROUP (00575.HK): Expected to Swing to Profit in First Half
Finance
Sisram Medical Ltd (01696.HK): Expected First-Half Loss of US$900,000 to US$1.4 Million
Finance
APEX ACE HOLDING (06036.HK): Expected Interim Profit of HK$130 Million to HK$140 Million
Research
Autonomous Driving Concept Stocks Watch | BIDU-SW (09888.HK) strengthens in afternoon trading；The regulatory compliance framework for the robotaxi industry continues to improve
ETF
Hang Seng China Enterprises Index ETF (02828.HK) Gains 0.34% Intraday, Turnover Reaches HK$5.287 Billion
ETF
Tracker Fund Of Hong Kong (02800.HK) Rises 0.08% Intraday, Total Asset Size Hits HK$142.579 Billion
ETF
Premia China Treasury And Policy Bank Bond Long Duration Etf (02817.HK) Rises 0.30% Intraday, NAV Per Unit Stands at HK$150.715
ETF
Invesco Qqq Trust (03455.HK) Rises 0.28% Intraday with Average Trading Price of HK$5,444.598
Scan QR Code
Download App
